Cargando…

A Comprehensive, Multi-Modal Strategy to Mitigate Alzheimer’s Disease Risk Factors Improves Aspects of Metabolism and Offsets Cognitive Decline in Individuals with Cognitive Impairment

BACKGROUND: Alzheimer’s disease (AD) is a chronic condition that progresses over time. While several therapeutic approaches have been developed, none have substantially altered disease progression. One explanation is that the disease is multi factorial. OBJECTIVE: Using the Affirmativ Health Persona...

Descripción completa

Detalles Bibliográficos
Autores principales: Schechter, Ginger, Azad, Gajendra Kumar, Rao, Rammohan, McKeany, Allison, Matulaitis, Matthew, Kalos, Denise M., Kennedy, Brian K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369137/
https://www.ncbi.nlm.nih.gov/pubmed/32715281
http://dx.doi.org/10.3233/ADR-200185
_version_ 1783560734889738240
author Schechter, Ginger
Azad, Gajendra Kumar
Rao, Rammohan
McKeany, Allison
Matulaitis, Matthew
Kalos, Denise M.
Kennedy, Brian K.
author_facet Schechter, Ginger
Azad, Gajendra Kumar
Rao, Rammohan
McKeany, Allison
Matulaitis, Matthew
Kalos, Denise M.
Kennedy, Brian K.
author_sort Schechter, Ginger
collection PubMed
description BACKGROUND: Alzheimer’s disease (AD) is a chronic condition that progresses over time. While several therapeutic approaches have been developed, none have substantially altered disease progression. One explanation is that the disease is multi factorial. OBJECTIVE: Using the Affirmativ Health Personal Therapeutic Program (PTPr), we sought to determine whether a comprehensive and personalized program could improve cognitive and metabolic function in individuals diagnosed with subjective cognitive impairment, mild cognitive impairment, and early stage AD. METHODS: 35 individuals submitted blood samples and Montreal Cognitive Assessment (MoCA) scores, and answered intake questions. Individuals and caregivers participated in a four-day immersion program, which included Personal Therapeutic Plans (PTP), consultations with clinical practitioners, and explanations of the PTPr and PTP. Participants had follow-up by telemonitoring, with repeat blood sample analysis, updates regarding lifestyle choices, current medications and supplements, and MoCA testing at least once between 3 and 12 months after the PTPr. RESULTS: By comparing baseline to follow-up testing, we determined several risk factor scores, including blood glucose and insulin levels, and levels of vitamins B12, D3, and E, improved either in the entire participant pool or specifically in individuals with measures outside the normal range for specific factors. MoCA scores were stabilized in the entire participant pool and significantly improved in individuals scoring 24 or less at baseline. CONCLUSION: Our findings provide evidence that a comprehensive and personalized approach designed to mitigate AD risk factors can improve risk factor scores and stabilize cognitive function, warranting more extensive and placebo-controlled clinical studies.
format Online
Article
Text
id pubmed-7369137
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-73691372020-07-24 A Comprehensive, Multi-Modal Strategy to Mitigate Alzheimer’s Disease Risk Factors Improves Aspects of Metabolism and Offsets Cognitive Decline in Individuals with Cognitive Impairment Schechter, Ginger Azad, Gajendra Kumar Rao, Rammohan McKeany, Allison Matulaitis, Matthew Kalos, Denise M. Kennedy, Brian K. J Alzheimers Dis Rep Research Report BACKGROUND: Alzheimer’s disease (AD) is a chronic condition that progresses over time. While several therapeutic approaches have been developed, none have substantially altered disease progression. One explanation is that the disease is multi factorial. OBJECTIVE: Using the Affirmativ Health Personal Therapeutic Program (PTPr), we sought to determine whether a comprehensive and personalized program could improve cognitive and metabolic function in individuals diagnosed with subjective cognitive impairment, mild cognitive impairment, and early stage AD. METHODS: 35 individuals submitted blood samples and Montreal Cognitive Assessment (MoCA) scores, and answered intake questions. Individuals and caregivers participated in a four-day immersion program, which included Personal Therapeutic Plans (PTP), consultations with clinical practitioners, and explanations of the PTPr and PTP. Participants had follow-up by telemonitoring, with repeat blood sample analysis, updates regarding lifestyle choices, current medications and supplements, and MoCA testing at least once between 3 and 12 months after the PTPr. RESULTS: By comparing baseline to follow-up testing, we determined several risk factor scores, including blood glucose and insulin levels, and levels of vitamins B12, D3, and E, improved either in the entire participant pool or specifically in individuals with measures outside the normal range for specific factors. MoCA scores were stabilized in the entire participant pool and significantly improved in individuals scoring 24 or less at baseline. CONCLUSION: Our findings provide evidence that a comprehensive and personalized approach designed to mitigate AD risk factors can improve risk factor scores and stabilize cognitive function, warranting more extensive and placebo-controlled clinical studies. IOS Press 2020-06-29 /pmc/articles/PMC7369137/ /pubmed/32715281 http://dx.doi.org/10.3233/ADR-200185 Text en © 2020 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Report
Schechter, Ginger
Azad, Gajendra Kumar
Rao, Rammohan
McKeany, Allison
Matulaitis, Matthew
Kalos, Denise M.
Kennedy, Brian K.
A Comprehensive, Multi-Modal Strategy to Mitigate Alzheimer’s Disease Risk Factors Improves Aspects of Metabolism and Offsets Cognitive Decline in Individuals with Cognitive Impairment
title A Comprehensive, Multi-Modal Strategy to Mitigate Alzheimer’s Disease Risk Factors Improves Aspects of Metabolism and Offsets Cognitive Decline in Individuals with Cognitive Impairment
title_full A Comprehensive, Multi-Modal Strategy to Mitigate Alzheimer’s Disease Risk Factors Improves Aspects of Metabolism and Offsets Cognitive Decline in Individuals with Cognitive Impairment
title_fullStr A Comprehensive, Multi-Modal Strategy to Mitigate Alzheimer’s Disease Risk Factors Improves Aspects of Metabolism and Offsets Cognitive Decline in Individuals with Cognitive Impairment
title_full_unstemmed A Comprehensive, Multi-Modal Strategy to Mitigate Alzheimer’s Disease Risk Factors Improves Aspects of Metabolism and Offsets Cognitive Decline in Individuals with Cognitive Impairment
title_short A Comprehensive, Multi-Modal Strategy to Mitigate Alzheimer’s Disease Risk Factors Improves Aspects of Metabolism and Offsets Cognitive Decline in Individuals with Cognitive Impairment
title_sort comprehensive, multi-modal strategy to mitigate alzheimer’s disease risk factors improves aspects of metabolism and offsets cognitive decline in individuals with cognitive impairment
topic Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369137/
https://www.ncbi.nlm.nih.gov/pubmed/32715281
http://dx.doi.org/10.3233/ADR-200185
work_keys_str_mv AT schechterginger acomprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment
AT azadgajendrakumar acomprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment
AT raorammohan acomprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment
AT mckeanyallison acomprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment
AT matulaitismatthew acomprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment
AT kalosdenisem acomprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment
AT kennedybriank acomprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment
AT schechterginger comprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment
AT azadgajendrakumar comprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment
AT raorammohan comprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment
AT mckeanyallison comprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment
AT matulaitismatthew comprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment
AT kalosdenisem comprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment
AT kennedybriank comprehensivemultimodalstrategytomitigatealzheimersdiseaseriskfactorsimprovesaspectsofmetabolismandoffsetscognitivedeclineinindividualswithcognitiveimpairment